Microbial solutions for a sustainable future
Driven by advances in genomics technology, rising oil prices, and a growing interest in ecological sustainability, the world is increasingly turning to industrial biotechnology to create renewable sources of products that either displace petrochemical-derived chemicals, or create novel biomaterials with commercially desirable properties. The applicable markets are broad and span food and feed ingredients, pharmaceuticals, as well as industrial chemicals.
We at Microbia have emerged as leaders in this field, having developed a proven technology platform that combines high-throughput biology with a proprietary approach to engineering microbial metabolic pathways. This platform enables us to produce high-quality, competitively-priced specialty and commodity chemicals from renewable resources.
A majority-owned subsidiary of Ironwood Pharmaceuticals, Microbia is building a sustainable specialty chemical business based on our validated and versatile industrial strain development platform, and has partnered with Tate & Lyle and others to develop novel technology for the production of industrial biomaterials.